Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.

Semaglutide use may be increasing worldwide rates of ischemic optic neuropathy and retinal adverse events, a study suggests.

Novo Nordisk stock climbs following the announcement of its plans to advance amycretin, a dual GLP-1/amylin agonist for ...

Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.

Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...